GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET) (original) (raw)

A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer

Randal Robinson

Fertility and Sterility, 2006

View PDFchevron_right

Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial

A. Pekin

Archives of Gynecology and Obstetrics, 2008

View PDFchevron_right

Initiation of Gonadotropin-Releasing Hormone Antagonist on Day 1 as Compared to Day 6 of Stimulation: Effect on Hormonal Levels and Follicular Development in in Vitro Fertilization Cycles

Michel Camus

The Journal of Clinical Endocrinology & Metabolism, 2003

View PDFchevron_right

Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation

Tamar Eldar

Reproductive Biomedicine Online, 2007

View PDFchevron_right

A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization

Samuel Chantilis

Fertility and Sterility, 2005

View PDFchevron_right

Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs

Raoul Orvieto

Fertility and Sterility, 2008

View PDFchevron_right

Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization–embryo transfer cycles

Ido Izhaki

Fertility and Sterility, 2010

View PDFchevron_right

Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration

Micah Hill

Fertility and Sterility, 2011

View PDFchevron_right

GnRH antagonists and mild ovarian stimulation for intrauterine insemination: a randomized study comparing different gonadotrophin dosages

Edgardo Somigliana

Human Reproduction, 2004

View PDFchevron_right

Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization–embryo transfer

Philippe Merviel, Emmanuelle Mathieu

Fertility and Sterility, 2004

View PDFchevron_right

The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on in vitro fertilization outcome

Samer Tannus

Fertility and Sterility, 2013

View PDFchevron_right

GnRH antagonists in IVF

Basil Tarlatzis, E. Kolibianakis, Paul Devroey

Reproductive BioMedicine Online, 2005

View PDFchevron_right

Comparison of GNRH Agonist with Low-Dose Urinary HCG for the Induction of Final Oocyte Maturation in High-Risk Patients Undergoing Intracytoplasmic Sperm Injection-Embryo Transfer (Icsi-Et)

Faiz Alwaeely

Basrah Journal of Surgery, 2013

View PDFchevron_right

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF

Raoul Orvieto

Reproductive Biology and Endocrinology

View PDFchevron_right

Are GnRH antagonists comparable to agonists for use in IVF?

Judith Huirne

Human Reproduction, 2007

View PDFchevron_right

The addition of GnRH antagonists in intrauterine insemination cycles: a pilot study

Roberto Marci

PubMed, 2013

View PDFchevron_right

GnRH antagonist for pituitary desensitization in IVF: Is it a time for a change of practice?

Mohamed Ahmed Youssef

Middle East Fertility Society Journal, 2011

View PDFchevron_right

GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity

Raoul Orvieto

Fertility and Sterility, 2008

View PDFchevron_right

GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study

Yannis Panagiotidis

Human Reproduction, 2005

View PDFchevron_right

Substituting HCG with GnRH agonist to trigger final follicular maturation – a retrospective comparison of three different ovarian stimulation protocols

Roy Homburg

Reproductive BioMedicine Online, 2006

View PDFchevron_right

Replacing GnRH agonists with GnRH antagonists in oocyte recipient cycle did not adversely affect the pregnancy rates

Elisabet Clua

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011

View PDFchevron_right

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study

arianna riva

Fertility and Sterility, 2011

View PDFchevron_right

A Randomized Comparison of Two Ovarian Stimulation Protocols with Gonadotropin-Releasing Hormone (GnRH) Antagonist Cotreatment forin VitroFertilization Commencing Recombinant Follicle-Stimulating Hormone on Cycle Day 2 or 5 with the Standard Long GnRH Agonist Protocol

Bart CJM Fauser

The Journal of Clinical Endocrinology & Metabolism, 2003

View PDFchevron_right

Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial

Frank Broekmans

Human Reproduction, 2013

View PDFchevron_right

GnRH antagonist in IVF poor-responder patients: results of a randomized trial

Massimo Moscarini

Reproductive BioMedicine Online, 2005

View PDFchevron_right

The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg

Sandra alvarez

Human Reproduction, 1998

View PDFchevron_right

A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders interv...

P. Braude

View PDFchevron_right

A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization

Inna Berin

Fertility and Sterility, 2010

View PDFchevron_right

Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes

Michael Kruger

Journal of Assisted Reproduction and Genetics, 2008

View PDFchevron_right

Extrapituitary effects of GnRH antagonists in assisted reproduction: a review

Hilde Riethmüller-Winzen

Reproductive BioMedicine Online, 2005

View PDFchevron_right